Skip to content
    Dementia Discovery Fund logo

    Dementia Discovery Fund

    London, United KingdomFounded 2015
    svhealthinvestors.com/ddf/dementia-discovery-fundLinkedIn
    Biotech & Life SciencesHealthcare

    The Dementia Discovery Fund (DDF), managed by SV Health Investors, is the world's largest family of specialized venture capital funds investing exclusively in companies developing or enabling novel therapeutics for dementia and other neurodegenerative diseases. Launched in October 2015, it creates and backs biotech ventures across the full spectrum from early-stage research to growth equity.

    64% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (42% of deals). Average disclosed round size is $50.9M (across 24 rounds with reported amounts).

    Find people at Dementia Discovery Fund on Goldilocks AI

    Portfolio

    21

    Fund Size

    $269M

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    CB

    Christian B. Jung

    Partner

    JB

    Jonathan Behr

    Partner

    GF

    Georgia Frost

    Vice President

    LR

    Lennart R. B. Spindler

    Associate

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    33 investments
    CompanyRoundAmountDate
    NRG Therapeutics logoNRG TherapeuticsSeries B$50MSep 2025
    Therini Bio logoTherini BioSeries A$39MMay 2025
    Sudo Biosciences logoSudo BiosciencesSeries B$147MJan 2024
    Sudo logoSudoSeries B$147MJan 2024
    LoQus23 logoLoQus23Series A—Jan 2024
    AstronauTx logoAstronauTxSeries A$61MOct 2023
    VViolet Therapeutics Inc.Seed$10.6MMay 2023
    Therini Bio logoTherini BioSeries A$75MApr 2023
    Transine Therapeutics logoTransine TherapeuticsSeed—May 2022
    AviadoBio logoAviadoBioSeed$16.5MDec 2021
    Nitrase Therapeutics logoNitrase TherapeuticsSeries A$45MNov 2021
    Transine Therapeutics logoTransine TherapeuticsSeed$12.8MJun 2021
    Alchemab logoAlchemabSeries A$60MApr 2021
    Alchemab Therapeutics logoAlchemab TherapeuticsSeries A$60MApr 2021
    AviadoBio logoAviadoBioSeries A$80MJan 2021
    Alchemab logoAlchemabSeries A$60MJan 2021
    Therini Bio logoTherini BioUnknown$17MJan 2021
    BBrainWaveBankSeed—Jul 2020
    Cerevance logoCerevanceSeries B$65MApr 2020
    Nitrase Therapeutics logoNitrase TherapeuticsSeries A$45MJan 2020
    NNitrome BiosciencesSeries A$38MJan 2020
    Therini Bio logoTherini BioSeed$9.3MJan 2020
    BBardydxSeries B—Apr 2019
    Alchemab logoAlchemabSeed—Jan 2019
    Alchemab Therapeutics logoAlchemab TherapeuticsSeed—Jan 2019
    Page 1 of 2

    Top Co-Investors

    SV Health Investors10 shared
    Dolby Family Ventures6 shared
    Sanofi Ventures5 shared
    Alexandria Venture Investments5 shared
    DCVC5 shared
    Monograph Capital4 shared
    AbbVie4 shared
    Sofinnova Partners4 shared
    Lightstone Ventures4 shared
    RA Capital Management4 shared
    Takeda Ventures, Inc.3 shared
    British Business Bank3 shared
    Novartis Venture Fund3 shared
    Amgen Ventures3 shared
    UPMC Enterprises3 shared
    LifeArc Ventures3 shared
    Epidarex Capital2 shared
    EQT Life Sciences2 shared
    Bristol Myers Squibb2 shared
    Brandon Capital2 shared

    Last updated: 20 October 2026